학술논문
Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma.
Document Type
Letter
Author
Source
World Journal of Pediatrics; Mar2024, Vol. 20 Issue 3, p287-293, 7p
Subject
Language
ISSN
17088569